[Pulmonary tuberculosis resistant to streptomycin and isoniazid and treated wtih a combination of ethionamide, pyrazinamide, and cycloserine (200 cases)].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D002648:Child; D003523:Cycloserine / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D009018:Morocco; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011718:Pyrazinamide / Q000627:therapeutic use*; D012008:Recurrence; D012111:Residence Characteristics; D012293:Rifampin / Q000627:therapeutic use; D012737:Sex Factors; D013307:Streptomycin / Q000494:pharmacology*; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Tuberculose pulmonaire résistante à la streptomycine plus isoniazide et traitée par l'association éthionamide, pyrazinamide et cyclosérine. (A propos de 200 cas)